Related Experiment Video

Updated: Jun 26, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

New insights into lipid metabolism in chronic kidney disease: what are the practical implications?

George A Kaysen1

  • 1Division of Nephrology, Department of Medicine and of Biochemistry and Molecular Medicine, UC Davis, Davis, Calif. 95616, USA. gakaysen@ucdavis.edu

Blood Purification
|January 27, 2009
PubMed

Insights

Cardiovascular disease risk rises with reduced kidney function. Lipid management benefits early chronic kidney disease patients but offers little benefit for dialysis patients, with bariatric surgery posing renal risks.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Declining kidney function, measured by glomerular filtration rate, correlates with increased cardiovascular disease (CVD) risk.
  • Hyperlipidemia and dyslipidemia, marked by elevated triglycerides and low high-density lipoprotein (HDL) levels, are linked to adverse cardiovascular outcomes and kidney function decline.
  • These lipid abnormalities are treatable through medications, lifestyle changes, and bariatric surgery.

Purpose of the Study:

  • To evaluate the impact of lipid-lowering therapies and bariatric surgery on cardiovascular and renal outcomes across different stages of chronic kidney disease (CKD).
  • To determine the efficacy of interventions based on the level of renal function.

Main Methods:

  • Review of evidence on pharmacologic therapies (HMG-CoA reductase inhibitors, fibric acid derivatives), dietary changes, and bariatric surgery in patients with varying degrees of kidney function.
  • Analysis of studies examining cardiovascular and renal outcomes in patients with stages 1-3 CKD and end-stage renal disease (dialysis patients).

Main Results:

  • Lipid-lowering therapy demonstrates significant cardiovascular risk reduction and potential slowing of renal function decline in patients with stages 1-3 CKD.
  • Treatment of low-density lipoprotein (LDL) cholesterol levels in dialysis patients yields minimal cardiovascular risk reduction.
  • Bariatric surgery effectively reduces hyperlipidemia in CKD patients but may accelerate renal decline due to oxalate deposition.

Conclusions:

  • Lipid management strategies should be tailored to the patient's level of renal function.
  • Early intervention with lipid-lowering therapy is beneficial for cardiovascular and renal health in early-stage CKD.
  • Caution is advised regarding bariatric surgery in CKD patients due to potential adverse renal effects.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...